MedPath

exploratory randomized clinical traial comparing naftopidil with tamsulosin in cases with benign prostatic hypertrophy assciated with overactive bladder

Not Applicable
Conditions
Benign prostatic hypertophy associated with overactive bladder
Registration Number
JPRN-UMIN000002119
Lead Sponsor
Department of Urology, the University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

1. residual volume>=50ml 2. cases with prostatic cancer, bladder cancer or interstitial cystitis 3. cases with urethral stricture 4. cases with diseases which may affect on the lower urinary tract symptoms such as diabate mellitus, cerebral vascular disease and spinal cord injury 5. cases with past history of allergic reaction to naftopidil or tamsulosin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
grade of desire for voiding measured by frequency volume chart
Secondary Outcome Measures
NameTimeMethod
frequency of voiding, maximum voiding volume, average voiding volume
© Copyright 2025. All Rights Reserved by MedPath